Cargando…
Dyspnoea in COVID-19 recovery beyond the intensive care unit: the potential impact of inspiratory muscle weakness
Emerging evidence confirms that dyspnoea and inspiratory muscle weakness persist for up to 6 months following mechanical ventilation with #COVID19 pneumonia. Screening for inspiratory muscle weakness should be prioritised, as it may be treatable. https://bit.ly/3CBQXO2
Autor principal: | Bissett, Bernie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841315/ https://www.ncbi.nlm.nih.gov/pubmed/36687360 http://dx.doi.org/10.1183/23120541.00521-2022 |
Ejemplares similares
-
Inspiratory muscle training to enhance recovery from mechanical ventilation: a randomised trial
por: Bissett, Bernie M, et al.
Publicado: (2016) -
Protocol: inspiratory muscle training for promoting recovery and outcomes in ventilated patients (IMPROVe): a randomised controlled trial
por: Bissett, Bernie M, et al.
Publicado: (2012) -
Weakness acquired in the intensive care unit. Incidence, risk factors
and their association with inspiratory weakness. Observational cohort
study
por: Ballve, Ladislao Pablo Diaz, et al.
Publicado: (2017) -
Nasopharyngeal abscess causing inspiratory dyspnoea in a domestic
cat
por: Slater, Annie, et al.
Publicado: (2023) -
Inspiratory Muscle Training in the Intensive Care Unit: A New Perspective
por: Tonella, Rodrigo Marques, et al.
Publicado: (2017)